Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

about

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

Item

http://www.wikidata.org/entity/Q40365236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immunogenicity, safety and ant ...... men in post-exposure subjects.

@en

type

Item

label

Immunogenicity, safety and ant ...... men in post-exposure subjects.

@en

prefLabel

Immunogenicity, safety and ant ...... men in post-exposure subjects.

@en

P1476

Immunogenicity, safety and ant ...... men in post-exposure subjects.

@en

P2093

Chun Yu

http://www.w3.org/2001/XMLSchema#string

Dingming Wang

http://www.w3.org/2001/XMLSchema#string

Fengji Luo

http://www.w3.org/2001/XMLSchema#string

Huizhen Zheng

http://www.w3.org/2001/XMLSchema#string

Junnan Zhang

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

Liqing Yang

http://www.w3.org/2001/XMLSchema#string

Nianmin Shi

http://www.w3.org/2001/XMLSchema#string

Qiang Lu

http://www.w3.org/2001/XMLSchema#string

Sihai Li

http://www.w3.org/2001/XMLSchema#string

P2860

Rabies trend in China (1990-2007) and post-exposure prophylaxis in the Guangdong province.

Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.

Molecular epidemiology of rabies in Southern People's Republic of China.

A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.

Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.

The spatial and temporal dynamics of rabies in China

Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers

Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups.

Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1279770

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28121231

http://www.w3.org/2001/XMLSchema#string

P921

Amorru

P932

5489304

http://www.w3.org/2001/XMLSchema#string